CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
256-270 of 921
Applying Perioperative ICIs in Clinical Practice
MinuteCE®Applying Perioperative ICIs in Clinical Practice
Managing Immune-Related Adverse Events in the Perioperative Setting
MinuteCE®Managing Immune-Related Adverse Events in the Perioperative Setting
Multidisciplinary Collaboration Facilitates Multimodality Therapy
MinuteCE®Multidisciplinary Collaboration Facilitates Multimodality Therapy
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CERisk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
- advertisement
Molecular Magic: Decoding the Unique Mechanism of CELMoDs
MinuteCE®Molecular Magic: Decoding the Unique Mechanism of CELMoDs
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
MinuteCE®Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
Mastering the Sequence: CELMoDs Across Treatment Lines
MinuteCE®Mastering the Sequence: CELMoDs Across Treatment Lines
Safety First: Navigating CELMoD-Associated Toxicities
MinuteCE®Safety First: Navigating CELMoD-Associated Toxicities
Real-World Ready: Practical Tips for Community Oncologists
MinuteCE®Real-World Ready: Practical Tips for Community Oncologists
- advertisement
Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
MinuteCE®Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Next-Generation Innovations: The Future of CELMoDs in Myeloma
MinuteCE®Next-Generation Innovations: The Future of CELMoDs in Myeloma
